Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

Howard Fillit shares his views on the historical research lag, the slim successes so far, and the target pathways that offer most hope

The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it

TUM Researchers create organoid that emulates the development of the human heart

Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F

PULSED – a self-sealing drug delivery depot – enables precise timing and tunable release of therapeutic doses

An insight into the complexities of Alzheimer’s disease and the ongoing pursuit for breakthrough therapies

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Sweedler talks shifting authorship geographies, the growth of data science, and developments in single-cell analysis over the past decade